Welcome to our dedicated page for Fmc news (Ticker: FMC), a resource for investors and traders seeking the latest updates and insights on Fmc stock.
FMC Corporation (NYSE: FMC) is a global agricultural sciences company focused on crop protection solutions, including biologicals, crop nutrition, and digital and precision agriculture. The FMC news feed on Stock Titan aggregates company-issued press releases and other coverage so readers can follow how this agricultural chemical manufacturer communicates its strategy, performance and product developments over time.
FMC regularly publishes earnings announcements and financial updates, including quarterly results, adjusted EBITDA and adjusted earnings per share metrics, along with commentary on regional performance in North America, Latin America, Asia and EMEA. The company also announces the timing of upcoming earnings releases and webcast conference calls, providing details for internet broadcasts and telephone access, as well as replay information.
Investors can track dividend declarations and changes to the dividend policy through FMC’s news releases, which have included both regular quarterly dividend announcements and a reduction in the quarterly dividend as part of a broader emphasis on debt reduction. The news flow also covers strategic and operational updates, such as the intention to divest the India commercial business, restructuring and cost actions, and initiatives like Project Foundation that are designed to reshape the manufacturing footprint and cost structure.
Product- and technology-related news is another key element of FMC’s disclosures. The company has reported regulatory registrations for products such as Fundatis herbicide powered by Isoflex active in Great Britain, and has highlighted the role of new active ingredients and biologicals in its growth portfolio and Plant Health business. Updates on registrations, launches and regional commercialization provide insight into FMC’s pipeline and portfolio evolution.
FMC’s news also includes leadership and governance updates, such as changes in executive roles and Board composition, and announcements that senior executives will speak at investor conferences hosted by firms like Goldman Sachs and Jefferies. For investors, analysts and others following the agricultural sciences sector, the FMC news page offers a centralized view of how the company reports its financial performance, portfolio developments and corporate actions.
Summary not available.
On December 19, 2022, FMC Corporation announced that it will release its fourth-quarter 2022 earnings on February 7, 2023, after market close. The earnings release will be available via PR Newswire and the company’s website. A webcast conference call is set for February 8, 2023, at 9:00 a.m. ET, offering a public forum for discussing results. The company is known for its commitment to innovative agricultural solutions, aiming to address global food security challenges. Investors can access the earnings call and further information through the provided links.
FMC Corporation (NYSE: FMC) announced that Dr. Kathleen Shelton will retire as executive vice president and chief technology officer on March 31, 2023, concluding a remarkable 33-year career in the chemical industry. Dr. Seva Rostovtsev, currently director of Discovery Chemistry, has been appointed as her successor. Under Shelton's leadership, FMC's R&D strategy has overseen a product innovation pipeline exceeding $2.5 billion in peak sales. Rostovtsev brings significant experience in crop protection chemistry and will lead FMC's global R&D efforts moving forward.
FMC Corporation (NYSE: FMC) has declared a quarterly dividend of 58 cents per share, payable on January 19, 2023, to shareholders of record as of December 30, 2022. This marks the fifth consecutive year of dividend increases, with a compound annual growth rate of 10 percent since establishing its current dividend policy in December 2018.
The company is dedicated to sustainable agricultural solutions, helping growers to adapt to changing environmental conditions.
Summary not available.
FMC Corporation (NYSE: FMC) has announced a strategic collaboration with Micropep Technologies to develop new micropeptide-based bioherbicides targeting herbicide-resistant weeds. This multi-year agreement aims to combine R&D capabilities to create sustainable weed control solutions for corn and soybeans. The global herbicide market exceeded $26 billion in 2021, with significant opportunities for environmentally-friendly bioherbicides. The collaboration seeks to expedite the availability of effective solutions amid growing agricultural challenges.
FMC Corporation reported third quarter 2022 revenue of $1.38 billion, up 15% year-over-year, driven by strong volume and pricing. However, GAAP net income fell 27% to $118 million, with adjusted earnings per share down 14% at $1.23. The company raised its full-year revenue outlook to $5.6-$5.8 billion, reflecting 13% growth. Adjusted EBITDA guidance was narrowed to $1.37-$1.43 billion, indicating 7% growth. Free cash flow expectations were reduced to $440-$560 million, citing inflation impacts.
FMC Corporation has appointed Dr. Bénédicte Flambard as vice president, joining the senior management Operating Committee while continuing to lead the Plant Health business. Under her leadership, the Plant Health division has significantly expanded, launching new biological products like Accudo® and Nema-C®, and acquiring BioPhero ApS. FMC is focusing on enhancing its position in the biologicals sector, which is a fast-growing segment of the company. Flambard will operate from FMC's European Innovation Center in Denmark.
FMC Corporation (NYSE: FMC) will release its third quarter 2022 earnings on November 1, 2022, after market close. The earnings will be accessible via PR Newswire and the company's website. A webcast conference call is scheduled for November 2, 2022, at 9:00 a.m. ET, where analysts can ask questions. The replay of the call will be available until November 23, 2022. FMC is focused on providing innovative crop protection solutions amid market challenges.
FMC Corporation (NYSE: FMC) reported a strong Q2 2022 performance with revenue reaching $1.45 billion, up 17% from Q2 2021, driven by robust market demand and effective pricing strategies. Adjusted earnings per diluted share increased 7% to $1.93, although GAAP net income fell 35% to $131 million. The company raised its full-year revenue outlook to $5.5-5.7 billion, reflecting 11% growth at the midpoint. However, costs are expected to rise significantly in Q3, impacting adjusted EBITDA forecasted at $235-255 million, a 16% decline year-over-year.
FAQ
What is the current stock price of Fmc (FMC)?
What is the market cap of Fmc (FMC)?
